-

Hologic to Webcast Presentation at the 43rd Annual J.P. Morgan Healthcare Conference

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that the Company will present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, at 1:30 p.m. Pacific Time.

The presentation and Q&A session will be webcast live and may be accessed through a link on the Investors section of Hologic’s website at http://investors.hologic.com. The webcast will be available for 30 days following the event.

About Hologic, Inc.

Hologic, Inc. is an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com.

SOURCE: Hologic, Inc.

Contacts

Paula Izidoro
Manager, Investor Relations and Social Media
(858) 410-8904
paula.izidoro@hologic.com

Hologic, Inc.

NASDAQ:HOLX

Release Summary
Hologic to Webcast Presentation at the 43rd Annual J.P. Morgan Healthcare Conference
Release Versions
$Cashtags
Hashtags

Contacts

Paula Izidoro
Manager, Investor Relations and Social Media
(858) 410-8904
paula.izidoro@hologic.com

Social Media Profiles
More News From Hologic, Inc.

Hologic to Webcast Presentation at the Raymond James 46th Annual Institutional Investors Conference

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic to Webcast Presentation at the Raymond James 46th Annual Institutional Investors Conference...

Hologic Obtains CE Mark for Affirm® Contrast Biopsy Software

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic Obtains CE Mark for Affirm® Contrast Biopsy Software...

Hologic Announces FDA Clearance of Aptima SARS-CoV-2 Assay

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic Announces FDA Clearance of Aptima SARS-CoV-2 Assay...
Back to Newsroom